ScholarLens Back to search
2008•Critical CareOpen access

Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study

Andrea Morelli, Christian Ertmer, Matthias Lange, Alessandra Orecchioni, Sebastian Rehberg, P Pietropaoli, Manfred Westphal

Open full text 6 citations

Abstract

The results of the Vasopressin in Septic Shock Trial suggest that early administration of vasopressin may be superior to a last resort treatment. However, it is still unknown whether vasopressin is superior to terlipressin. We therefore performed a randomized study to compare the efficacy and safety of continuous infusions of either vasopressin or terlipressin as first-line therapy in patients with septic shock.

Open-access reader

About this research paper

What this paper is about

The results of the Vasopressin in Septic Shock Trial suggest that early administration of vasopressin may be superior to a last resort treatment. However, it is still unknown whether vasopressin is superior to terlipressin. We therefore performed a randomized study to compare the efficacy and safety of continuous infusions of either vasopressin or terlipressin as first-line therapy in patients with septic shock.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The results of the Vasopressin in Septic Shock Trial suggest that early administration of vasopressin may be superior to a last resort treatment. However, it is still unknown whether vasopressin is superior to terlipressin. We therefore performed a randomized study to compare the efficacy and safety of continuous infusions of either vasopressin or terlipressin as first-line therapy in patients with septic shock.

Key concepts: Terlipressin, Vasopressin, Medicine, Septic shock, Shock (circulatory), Anesthesia, Intensive care medicine, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study — Research Paper | ScholarLens